Mesenchymal stem cells (MSC) have emerged as breakthrough treatments for myocardial infarction. However, the efficacy of MSC remains unclear. The aim of the study was to evaluate treatment effect of MSC in terms of mechanical, regenerative, and clinical outcomes for patients with myocardial infarction (MI) using meta-analysis.
MSC's in Tx of Ischemic Heart Disease Feb 2018Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis
By nsc116|2018-07-16T14:18:10+00:00July 16th, 2018|Ischemic Stroke, Mesenchymal Stem Cells, Stem Cells|Comments Off on Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis